CN Stock MarketDetailed Quotes

Beijing Sun-Novo Pharmaceutical Research (688621)

Watchlist
  • 75.88
  • +0.33+0.44%
Market Closed Jan 16 15:00 CST
8.50BMarket Cap63.87P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Sun-Novo Pharmaceutical Research (688621) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-6.65%855.76M
4.87%590.3M
-8.49%230.84M
15.70%1.08B
32.47%916.68M
22.08%562.86M
8.53%252.26M
37.76%932.12M
39.73%692M
42.16%461.05M
Operating revenue
-6.65%855.76M
4.87%590.3M
-8.49%230.84M
15.70%1.08B
32.47%916.68M
22.08%562.86M
8.53%252.26M
37.76%932.12M
39.73%692M
42.16%461.05M
Total operating cost
-1.24%661.73M
12.82%438.34M
14.70%197.75M
26.97%872.21M
38.04%670.05M
22.52%388.53M
0.68%172.41M
35.63%686.94M
37.45%485.4M
40.68%317.12M
Operating cost
-3.91%421.5M
15.26%285.54M
20.96%123.34M
33.08%537.33M
44.38%438.66M
24.75%247.73M
-13.50%101.97M
34.08%403.77M
42.38%303.83M
47.08%198.59M
Operating tax surcharges
72.75%2.13M
148.20%1.53M
449.52%1.86M
60.39%2M
42.83%1.23M
36.27%617.62K
189.70%338.54K
11.84%1.25M
2.79%863.09K
-18.84%453.25K
Operating expense
-6.96%28.29M
1.38%17.69M
-3.98%8.17M
0.80%44.14M
56.71%30.4M
47.37%17.45M
29.22%8.51M
116.01%43.79M
34.95%19.4M
19.81%11.84M
Administration expense
15.79%84.18M
4.45%51.1M
-1.54%24.28M
-2.88%106.3M
-2.82%72.7M
-3.60%48.92M
-7.21%24.66M
20.88%109.45M
14.60%74.81M
20.95%50.75M
Financial expense
33.83%10.1M
31.60%6.2M
20.60%2.36M
110.11%10.5M
124.45%7.55M
121.88%4.71M
160.75%1.96M
33.92%5M
31.46%3.36M
14.24%2.12M
-Interest expense (Financial expense)
1.22%12.28M
-6.02%7.85M
-22.02%3.22M
32.26%16.11M
47.01%12.13M
59.87%8.35M
76.29%4.13M
25.55%12.18M
14.89%8.25M
12.82%5.22M
-Interest Income (Financial expense)
51.68%-2.24M
54.10%-1.68M
57.32%-931.94K
21.71%-5.67M
6.09%-4.63M
-17.14%-3.67M
-35.76%-2.18M
-17.69%-7.24M
-5.91%-4.93M
-12.06%-3.13M
Research and development
-3.32%115.53M
10.39%76.27M
7.90%37.73M
39.02%171.94M
43.76%119.51M
29.48%69.09M
80.85%34.97M
37.91%123.68M
46.61%83.13M
47.71%53.36M
Credit Impairment Loss
-21.23%-41.45M
0.48%-26.78M
-65.95%-21.71M
26.42%-44.28M
-18.17%-34.19M
-33.01%-26.91M
-28.12%-13.08M
-209.52%-60.18M
-102.62%-28.94M
-143.97%-20.23M
Other net revenue
Invest income
281.09%1.21M
-766.05%-1.55M
338.06%697.61K
-240.93%-1.82M
-33.83%317.92K
-27.48%232.92K
-0.04%159.25K
-50.80%1.29M
-81.05%480.43K
-87.13%321.18K
-Including: Investment income associates
--224.43K
---3.03M
----
---4.68M
----
----
----
----
----
----
Asset deal income
---18.45K
---132.92K
----
----
----
----
----
----
----
----
Other revenue
70.10%15.91M
60.29%13.93M
51.52%11.36M
122.86%17.53M
75.86%9.35M
91.35%8.69M
462.24%7.5M
-50.89%7.87M
-34.37%5.32M
-3.57%4.54M
Operating profit
-23.60%169.68M
-12.10%137.42M
-68.51%23.44M
-8.48%177.69M
21.06%222.11M
21.62%156.34M
41.85%74.43M
14.70%194.16M
32.51%183.47M
31.44%128.56M
Add:Non operating Income
8.12%2.17K
-41.65%1.17K
-99.89%2.11
83.25%18.47K
-76.74%2.01K
-61.07%2K
75.70%2K
-89.49%10.08K
4.46%8.63K
-17.87%5.14K
Less:Non operating expense
7.92%1.7M
-4.18%1.46M
38.22%169.73K
122.07%1.72M
215.93%1.58M
2,173.89%1.53M
134.19%122.8K
233.66%774.6K
167.15%499.9K
1,722.63%67.21K
Total profit
-23.83%167.98M
-12.18%135.96M
-68.68%23.27M
-9.00%175.99M
20.52%220.53M
20.49%154.82M
41.76%74.31M
14.34%193.4M
32.32%182.98M
31.37%128.49M
Less:Income tax cost
-77.83%3.71M
-49.91%6.75M
-173.27%-4.08M
-33.59%6.97M
61.95%16.73M
46.65%13.47M
23.13%5.57M
0.65%10.5M
30.36%10.33M
-14.60%9.19M
Net profit
-19.40%164.27M
-8.59%129.21M
-60.21%27.35M
-7.59%169.01M
18.04%203.8M
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
Net profit from continuing operation
-19.40%164.27M
-8.59%129.21M
-60.21%27.35M
-7.59%169.01M
18.04%203.8M
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
Less:Minority Profit
125.31%984.3K
91.36%-623.8K
44.48%-2.23M
-350.84%-8.4M
-347.27%-3.89M
-649.40%-7.22M
-10,351.48%-4.01M
-183.48%-1.86M
8.28%1.57M
503.24%1.31M
Net profit of parent company owners
-21.38%163.29M
-12.61%129.83M
-59.34%29.58M
-3.98%177.41M
21.40%207.69M
25.91%148.57M
51.77%72.75M
18.08%184.76M
32.72%171.08M
35.03%117.99M
Earning per share
Basic earning per share
-19.46%1.49
-11.28%1.18
-59.09%0.27
-4.24%1.58
20.92%1.85
26.67%1.33
53.49%0.66
17.86%1.65
33.04%1.53
34.62%1.05
Diluted earning per share
-19.46%1.49
-11.28%1.18
-59.09%0.27
-4.24%1.58
20.92%1.85
26.67%1.33
53.49%0.66
17.86%1.65
33.04%1.53
34.62%1.05
Other composite income
Total composite income
-19.40%164.27M
-8.59%129.21M
-60.21%27.35M
-7.59%169.01M
18.04%203.8M
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
Total composite income of parent company owners
-21.38%163.29M
-12.61%129.83M
-59.34%29.58M
-3.98%177.41M
21.40%207.69M
25.91%148.57M
51.77%72.75M
18.08%184.76M
32.72%171.08M
35.03%117.99M
Total composite income of minority owners
125.31%984.3K
91.36%-623.8K
44.48%-2.23M
-350.84%-8.4M
-347.27%-3.89M
-649.40%-7.22M
-10,351.48%-4.01M
-183.48%-1.86M
8.28%1.57M
503.24%1.31M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
--
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -6.65%855.76M4.87%590.3M-8.49%230.84M15.70%1.08B32.47%916.68M22.08%562.86M8.53%252.26M37.76%932.12M39.73%692M42.16%461.05M
Operating revenue -6.65%855.76M4.87%590.3M-8.49%230.84M15.70%1.08B32.47%916.68M22.08%562.86M8.53%252.26M37.76%932.12M39.73%692M42.16%461.05M
Total operating cost -1.24%661.73M12.82%438.34M14.70%197.75M26.97%872.21M38.04%670.05M22.52%388.53M0.68%172.41M35.63%686.94M37.45%485.4M40.68%317.12M
Operating cost -3.91%421.5M15.26%285.54M20.96%123.34M33.08%537.33M44.38%438.66M24.75%247.73M-13.50%101.97M34.08%403.77M42.38%303.83M47.08%198.59M
Operating tax surcharges 72.75%2.13M148.20%1.53M449.52%1.86M60.39%2M42.83%1.23M36.27%617.62K189.70%338.54K11.84%1.25M2.79%863.09K-18.84%453.25K
Operating expense -6.96%28.29M1.38%17.69M-3.98%8.17M0.80%44.14M56.71%30.4M47.37%17.45M29.22%8.51M116.01%43.79M34.95%19.4M19.81%11.84M
Administration expense 15.79%84.18M4.45%51.1M-1.54%24.28M-2.88%106.3M-2.82%72.7M-3.60%48.92M-7.21%24.66M20.88%109.45M14.60%74.81M20.95%50.75M
Financial expense 33.83%10.1M31.60%6.2M20.60%2.36M110.11%10.5M124.45%7.55M121.88%4.71M160.75%1.96M33.92%5M31.46%3.36M14.24%2.12M
-Interest expense (Financial expense) 1.22%12.28M-6.02%7.85M-22.02%3.22M32.26%16.11M47.01%12.13M59.87%8.35M76.29%4.13M25.55%12.18M14.89%8.25M12.82%5.22M
-Interest Income (Financial expense) 51.68%-2.24M54.10%-1.68M57.32%-931.94K21.71%-5.67M6.09%-4.63M-17.14%-3.67M-35.76%-2.18M-17.69%-7.24M-5.91%-4.93M-12.06%-3.13M
Research and development -3.32%115.53M10.39%76.27M7.90%37.73M39.02%171.94M43.76%119.51M29.48%69.09M80.85%34.97M37.91%123.68M46.61%83.13M47.71%53.36M
Credit Impairment Loss -21.23%-41.45M0.48%-26.78M-65.95%-21.71M26.42%-44.28M-18.17%-34.19M-33.01%-26.91M-28.12%-13.08M-209.52%-60.18M-102.62%-28.94M-143.97%-20.23M
Other net revenue
Invest income 281.09%1.21M-766.05%-1.55M338.06%697.61K-240.93%-1.82M-33.83%317.92K-27.48%232.92K-0.04%159.25K-50.80%1.29M-81.05%480.43K-87.13%321.18K
-Including: Investment income associates --224.43K---3.03M-------4.68M------------------------
Asset deal income ---18.45K---132.92K--------------------------------
Other revenue 70.10%15.91M60.29%13.93M51.52%11.36M122.86%17.53M75.86%9.35M91.35%8.69M462.24%7.5M-50.89%7.87M-34.37%5.32M-3.57%4.54M
Operating profit -23.60%169.68M-12.10%137.42M-68.51%23.44M-8.48%177.69M21.06%222.11M21.62%156.34M41.85%74.43M14.70%194.16M32.51%183.47M31.44%128.56M
Add:Non operating Income 8.12%2.17K-41.65%1.17K-99.89%2.1183.25%18.47K-76.74%2.01K-61.07%2K75.70%2K-89.49%10.08K4.46%8.63K-17.87%5.14K
Less:Non operating expense 7.92%1.7M-4.18%1.46M38.22%169.73K122.07%1.72M215.93%1.58M2,173.89%1.53M134.19%122.8K233.66%774.6K167.15%499.9K1,722.63%67.21K
Total profit -23.83%167.98M-12.18%135.96M-68.68%23.27M-9.00%175.99M20.52%220.53M20.49%154.82M41.76%74.31M14.34%193.4M32.32%182.98M31.37%128.49M
Less:Income tax cost -77.83%3.71M-49.91%6.75M-173.27%-4.08M-33.59%6.97M61.95%16.73M46.65%13.47M23.13%5.57M0.65%10.5M30.36%10.33M-14.60%9.19M
Net profit -19.40%164.27M-8.59%129.21M-60.21%27.35M-7.59%169.01M18.04%203.8M18.47%141.35M43.52%68.74M15.24%182.9M32.44%172.65M37.05%119.31M
Net profit from continuing operation -19.40%164.27M-8.59%129.21M-60.21%27.35M-7.59%169.01M18.04%203.8M18.47%141.35M43.52%68.74M15.24%182.9M32.44%172.65M37.05%119.31M
Less:Minority Profit 125.31%984.3K91.36%-623.8K44.48%-2.23M-350.84%-8.4M-347.27%-3.89M-649.40%-7.22M-10,351.48%-4.01M-183.48%-1.86M8.28%1.57M503.24%1.31M
Net profit of parent company owners -21.38%163.29M-12.61%129.83M-59.34%29.58M-3.98%177.41M21.40%207.69M25.91%148.57M51.77%72.75M18.08%184.76M32.72%171.08M35.03%117.99M
Earning per share
Basic earning per share -19.46%1.49-11.28%1.18-59.09%0.27-4.24%1.5820.92%1.8526.67%1.3353.49%0.6617.86%1.6533.04%1.5334.62%1.05
Diluted earning per share -19.46%1.49-11.28%1.18-59.09%0.27-4.24%1.5820.92%1.8526.67%1.3353.49%0.6617.86%1.6533.04%1.5334.62%1.05
Other composite income
Total composite income -19.40%164.27M-8.59%129.21M-60.21%27.35M-7.59%169.01M18.04%203.8M18.47%141.35M43.52%68.74M15.24%182.9M32.44%172.65M37.05%119.31M
Total composite income of parent company owners -21.38%163.29M-12.61%129.83M-59.34%29.58M-3.98%177.41M21.40%207.69M25.91%148.57M51.77%72.75M18.08%184.76M32.72%171.08M35.03%117.99M
Total composite income of minority owners 125.31%984.3K91.36%-623.8K44.48%-2.23M-350.84%-8.4M-347.27%-3.89M-649.40%-7.22M-10,351.48%-4.01M-183.48%-1.86M8.28%1.57M503.24%1.31M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------------Unqualified opinion----
Auditor --------------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -